Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer’s Disease
Year: 2017
Type: article
Study design: Observational Study
Abstract: Alzheimer's disease (AD) may have heterogeneous pathophysiological underpinnings, with risk factors including apolipoprotein rmvarep4 (APOE4) genotype and insulin resistance. We hypothesized that distinct phenotypes exist within AD. We examined APOE4 and metabolic biomarkers in 338 subjects (n = 213 nondemented (ND), n = 125 AD). We further characterized steady state free fatty acid (FFA) levels in a subset of 45 participants who had also participated in a hyperinsulinemic-euglycemic clamp. Insulin resistance (HOMA-IR) was elevated in AD versus ND (p = 0.04) and in APOE4 noncarriers versus carriers (p < 0.01). This was driven by increased fasting insulin in AD versus ND (p < 0.01) and in APOE4 non-carriers versus carriers (p = 0.01). Fasting glucose was not different. In subjects who underwent a clamp, there was a group x genotype interaction on FFA levels during hyperinsulinemia (p = 0.03). APOE4 non-carriers with AD had higher FFA levels, while APOE4 carriers with AD exhibited lower FFA levels. Metabolic dysfunction is overrepresented in individuals with AD dementia who do not carry the APOE4 allele. This suggests that important subsets of AD phenotypes may exist that diverge metabolically.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-170148
Institutions: University of Kansas, University of Kansas Medical Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, APOE ε4 genotype
Open Access status: green
Funders: U.S. Department of Veterans Affairs, National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: Effect of Aerobic Exercise on Alzheimer's Pathophysiology in Preclinical AD, FFA Production From Triglyceride-Rich Lipoproteins, Metabolic hormones, aging, and Alzheimer's Disease, Aerobic fitness, mitochondrial dysfunction, and fatty liver disease, University of Kansas Alzheimer's Disease Core Centers, Heartland Institute for Clinical and Translational Research, Kansas Intellectual and Developmental Disabilities Research Center (KIDDRC), G8355484434, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
OpenAlex ID: W2619594039
